Collagen Drinks - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The collagen drinks market size is expected to grow from USD 393.22 million in 2025 to USD 430.81 million in 2026 and is forecast to reach USD 671.24 million by 2031 at 9.27% CAGR over 2026-2031. This report is Segmented by Source (Animal-Based Drinks, Marine-Based Drinks), Packaging Type (PET/Glass Bottle, Cans, Pouches/Sachets), Distribution Channel (Supermarkets/Hypermarkets, Online Retail Stores, Beauty/Health Wellness Stores, Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Liter).

Global Collagen Drinks Market Trends and Insights

Rising consumer focus on holistic well-being and preventive health fuels demand

Preventive health spending has transitioned from occasional supplementation to daily routines, with collagen drinks becoming essential for beauty-conscious consumers. Regular intake of oral collagen peptides has been proven to improve skin hydration and elasticity within weeks, making them particularly appealing to aging populations. This shift is driven by the increasing number of older adults. For example, in 2024, individuals aged 65 and above accounted for 10% of the global population, according to the United Nations (UN). Additionally, the U.S. FDA's GRAS approvals for hydrolyzed pork cartilage collagen (GRN 713) and E. coli-derived collagen polypeptides (GRN 1171) have expanded formulation options. This enables brands to enhance ready-to-drink beverages without classifying them under dietary-supplement regulations. The primary consumers of premium collagen drinks prioritize ingredient transparency and clinical validation over cost. Significantly, this group is willing to pay a 30-50% premium for collagen derived from marine or fermentation sources, creating substantial opportunities for innovation and profit margins.

Influence of social media and celebrity endorsements

Digital discovery channels have accelerated the transition from awareness to purchase. Influencer partnerships effectively drive trials among Gen Z and millennials, who collectively contribute over 41% of wellness spending. In February 2025, HEYTEA partnered with Vida Glow to introduce collagen shots into bubble-tea menus at 3,000 outlets across China. This initiative demonstrates how cross-category collaborations can expand reach beyond traditional supplement aisles. In 2024, Thailand's FDA targeted e-commerce supplement listings, identifying over 80% for noncompliant advertising. This action highlights a significant enforcement gap between digital and physical retail, creating compliance challenges for brands heavily reliant on influencer marketing. The growing preference for short-form video content on platforms like TikTok and Instagram Reels emphasizes visually demonstrable benefits, such as skin glow and hair thickness, over claims related to joint or bone health, which require longer validation periods. This shift is driving product development toward marine collagen's Type I composition, valued for its visible skin benefits, rather than bovine collagen's Type I and Type III blend, which supports structural health. South Korea's stricter labeling requirements, effective January 1, 2026, for products containing guarana and sugar alcohols, aim to reduce misleading wellness claims. However, these regulations may inadvertently benefit established brands with regulatory teams over digitally native startups.

Source traceability and quality-control gaps

Brands are exposed to contamination risks and regulatory penalties due to supply-chain opacity. A 2024 study in the Journal of Food Science found that 30% of collagen supplements tested contained undeclared species or synthetic additives. Notably, some samples exceeded FDA and EFSA thresholds for heavy-metal concentrations. Although ISO 22000 food safety management and HACCP certification establish baseline controls, enforcement varies widely across regions. China's General Administration of Customs Decree No. 280, effective June 1, 2026, strengthens import protocols for collagen products by requiring full ingredient disclosure and third-party contaminant testing. This regulation delays market entry and increases compliance costs. Marine collagen, sourced from fish-processing byproducts, shows variability in peptide composition and bioavailability based on species, tissue type, and extraction method. Brands relying on suppliers from Southeast Asia and South America face increased scrutiny due to inconsistent quality-management practices and inadequate traceability infrastructure. In July 2025, Nitta Gelatin expanded its annual capacity by 550 metric tons in Kerala, India, integrating blockchain-based traceability systems. This initiative highlights the industry's recognition of these challenges.

Other drivers and restraints analyzed in the detailed report include:

• Product innovation and formulation advancements
• Growth in functional and fortified beverage category
• Competition from alternative nutricosmetic formats

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Marine-based drinks are projected to grow at a CAGR of 10.36% from 2026 to 2031, surpassing the animal-based segment, which is expected to hold an 89.36% share in 2025. This growth is driven by superior bioavailability and sustainability narratives. Marine collagen, with its smaller peptide size of 2,000-5,000 daltons, reaches peak plasma concentration within 1-2 hours, approximately 1.5 times faster than bovine collagen. This enables brands to position marine variants as premium efficacy products. In June 2025, Thai Union announced a USD 30 million investment in a marine-collagen facility. This facility, which produces ThalaCol peptides from fish-processing byproducts, highlights the company's vertical integration strategy. This approach not only captures margins across the value chain but also reduces reliance on third-party suppliers. The sustainability strategy leverages fish-processing byproducts, such as skin, scales, and bones, that account for 25-70% of the total catch weight. This reduces waste and lowers the carbon footprint compared to bovine sources, which require dedicated livestock. However, marine collagen's premium pricing, 30-50% higher than bovine alternatives, limits its adoption among price-sensitive consumers, restricting growth to affluent urban markets in North America, Western Europe, and the Asia-Pacific region.

Animal-based drinks maintain their dominance due to cost efficiency and multi-benefit positioning. Bovine collagen, which combines Type I and Type III variants, supports skin, joint, and muscle health. This expands its appeal to include not only beauty-conscious consumers but also those in the active-aging and sports-nutrition segments. Established supply chains and regulatory approvals, such as the U.S. FDA's GRAS determination for hydrolyzed pork cartilage collagen (GRN 713), enable rapid formulation adjustments and market entry for bovine collagen. However, ethical and religious factors constrain its addressable market. Hindu consumers avoid bovine products, Muslim consumers require halal certification, and vegan consumers reject all animal-derived ingredients. While porcine collagen complies with halal standards, it faces acceptance challenges in regions with significant Muslim populations, leading to fragmentation within the animal-based segment.

Complete Report Scope:

• By Source
  • Animal-Based Drinks
  • Marine-Based Drinks
• By Packaging Type
  • PET/ Glass Bottle
  • Cans
  • Pouches/Sachets
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Online Retail Stores
  • Beauty/Health Wellness Stores
  • Other Distribution Channels
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Thailand
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • South Africa
    • Saudi Arabia
    • Rest of Middle East and Africa

Geography Analysis

In 2025, North America accounted for 37.03% of the revenue, driven by the United States' advanced wellness infrastructure and consumers' willingness to pay a premium for clinically validated products. The U.S. FDA's GRAS approvals for hydrolyzed pork cartilage collagen (GRN 713) and E. coli-derived collagen polypeptides (GRN 1171) expanded formulation options, allowing brands to enhance ready-to-drink beverages without falling under dietary-supplement regulations. In Canada, the Natural and Non-prescription Health Products Directorate requires product licensing for collagen drinks with health claims, creating a regulatory advantage for established brands with regulatory teams over newer, digitally native startups. Mexico's expanding middle class and growing health awareness offer growth opportunities, but challenges such as distribution infrastructure and cold-chain limitations hinder expansion beyond urban areas.

Asia-Pacific, led by China's strong market, is expected to grow at a CAGR of 10.27% from 2026 to 2031. This growth is fueled by increasing disposable incomes, a beauty-conscious population, and innovative developments by regional leaders. According to China's National Bureau of Statistics, the average annual per capita disposable income for households rose from 39,218 yuan in 2023 to approximately 41,300 yuan in 2024, indicating rising demand. China's General Administration of Customs, through Decree No. 280, has tightened import requirements for collagen products, mandating full ingredient disclosure and third-party contaminant testing. While these regulations, effective June 1, 2026, may delay market entry and increase compliance costs, they enhance product safety. Starting September 1, 2026, Japan's Consumer Affairs Agency will require mandatory Foods with Function Claims labeling, which obligates brands to provide clinical evidence and safety data. This regulation creates a clear pathway for brands to differentiate functional foods from generic supplements. In Australia, the expiration of Therapeutic Goods Order 92 on October 1, 2026, reclassifies oral collagen drinks with cosmetic claims as therapeutic goods. This change requires listing on the Australian Register of Therapeutic Goods, increasing compliance costs but reinforcing the product's safety appeal to consumers. Indonesia's mandatory halal certification, effective October 17, 2026, adds compliance requirements, favoring marine or fermentation-derived collagen sources over bovine options.

Europe is experiencing regulatory shifts. The European Food Safety Authority's rejection of all oral-collagen health claims on March 30, 2026, has removed the option for efficacy messaging across the EU's 27 member states. This forces brands to reformulate or pivot to structure-function messaging. While the United Kingdom's post-Brexit alignment with EFSA standards ensures consistency for brands operating across Europe, potential divergence may arise as the UK Food Standards Agency develops its independent framework. Germany, France, and Italy lead Europe's market, with consumers favoring clean-label and natural ingredients. However, as disposable incomes grow and wellness awareness increases, Spain and Eastern European markets present new growth opportunities. South America and the Middle East and Africa remain emerging markets. Brazil's beauty-conscious consumers and the affluent expatriate population in the United Arab Emirates offer early-mover opportunities, but challenges such as distribution infrastructure, regulatory frameworks, and consumer education needs limit immediate market penetration.

List of Companies Covered in this Report:

• Shiseido Company, Limited
• Meiji Holdings Co., Ltd.
• Nestle S.A.
• Amorepacific Corp. (Vitalbeautie)
• Kino Biotech Co., Ltd (Kinohimitsu)
• Kirin Holdings Co., Ltd (FANCL)
• Suntory Holdings Ltd.
• DHC Corporation
• Minerva Research Labs (Gold Collagen)
• Beautiful Drinks Co. Ltd (Skinade)
• Vida Glow
• LAC Global (Taut)
• Swisse Wellness Pty Ltd.
• Youtheory (Nutrawise Health and Beauty LLC)
• Neocell Corporation
• ReFa (MTG Co., Ltd.)
• The Protein Drinks Co.
• TCI Co., Ltd.
• Dose and Co. (New Zealand Collagen Co.)
• Asterism Healthcare+ (Colla Rich)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support